Analysis of expression of an alternative La (SS-B) cDNA and localization of the encoded N- and C-terminal peptides  by Bachmann, Michael et al.
 .Biochimica et Biophysica Acta 1356 1997 53–63
 /Analysis of expression of an alternative La SS-B cDNA and
localization of the encoded N- and C-terminal peptides
Michael Bachmann ), Daniel Grolz, Holger Bartsch, Rolf R. Klein, Helmut Troster¨ ¨
Institut fur Physiologische Chemie, Johannes Gutenberg Uni˝ersitat Mainz, Duesbergweg 6, D-55099 Mainz, Germany¨ ¨
Received 30 September 1996; accepted 16 October 1996
Abstract
 .A deletion of an A -residue was detected in a cDNA encoding for the nuclear autoantigen LarSS-B. The cDNA was
recently isolated from a cDNA library made from peripheral blood lymphocytes of a patient with primary Sjogren’s¨
 .Syndrome. The region, where the deletion occurred, represents a hot spot region in the La gene s . It leads to a frame shift
mutation and a premature stop codon eleven amino acids downstream of the deletion site within one of the protease
sensitive regions of the La protein. In spite of the frame shift mutation expression of full length La protein occurred
efficiently in E. coli. Full length La protein was also made in SF9 cells infected with recombinant baculoviruses, although
the efficiency of full length protein production was less. Two major peptides with molecular weights of 29 kDa and 25 kDa
were made. The size of these peptides was similar to the known proteolytic degradation products of La protein. The
N-terminal 29 kDa fragment containing the RNP consensus sequence located in the cytoplasm. The 25 kDa C-terminal
fragment containing the nuclear location signal entered in the nucleus and associated with nuclear speckles. In conclusion,
 .  .  .the ability to i enter, ii remain in the nucleus and iii assemble with nuclear speckles resides in the C-terminal domain of
La protein and does not depend on the N-terminal RNP-consensus motif.
1. Introduction
Sera of patients with systemic immuno-inflamma-
tory diseases such as Systemic Lupus Erythematosus
 .  .SLE or primary Sjogrens Syndrome pSS fre-¨
w xquently contain autoantibodies to nuclear antigens 1 .
 .The La also known as SS-B antigen constitutes one
 .of the targets of such anti-nuclear antibodies ANAs .
La protein was found to associate with nearly all
RNA polymerase III transcripts at least transiently as
well as with a series of leader RNAs of different
w xviruses 2,3 . The La protein was described as a
protein with a molecular weight of about 50 kDa. It
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consists of two domains which are connected by an
a-helical stretch that is very sensitive to proteolysis.
Cleavage of La protein results in the release of a
N-terminal 29 kDa and a C-terminal 25 kDa fragment
w x4 . The N-terminal fragment contains a RNP-motif,
that has been shown to be both, required and suffi-
w xcient for RNA binding 5,6 . The C-terminal fragment
 .was determined to start at the amino acid aa me-
 . w xthionine 223 M223 4 . It contains two regions
similar to sequence elements of double-stranded
RNA-activated protein kinase PKR, the nuclear loca-
 .tion signal NLS and a putative ATP-binding site
w x7–9 .
A variety of staining pattern had been reported in
the literature for anti-La antibodies including a nu-
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clear speckled type pattern, a homogenous nuclear
staining, a cytoplasmic staining, and a staining of
w w xxboth compartments summarized in 10 . In some
cases, especially after virus infections a nucleocyto-
plasmic translocation was reported including infec-
w xtion with herpes simplex virus type I 10 and po-
w xliovirus 11 . Moreover, a leakage of La protein
during fixation was suggested to be responsible for
the cytoplasmic staining of anti-La antibodies.
La protein was assumed to be involved in tran-
w xscription termination of RNA polymerase III 12,13 .
In addition, La protein was proposed to be involved
in internal initiation of translation at least in po-
w xliovirus infected cells 11 .
Most recently five La cDNAs were isolated, when
a cDNA library made from peripheral blood lympho-
 .cytes PBL of a patient with pSS was screened with
w xher own anti-La serum 14 . In two of these five La
cDNAs the exon 1 was replaced with an alternative
exon termed exon 1X.
Here we report that one of the two exon 1X La
 .cDNAs contained a deletion of an A -residue in the
protease sensitive peptide region which connects the
two domains of the La protein. In spite of the frame
shift mutation full length recombinant La protein was
efficiently made when the deletion mutant was ex-
pressed in E. coli. Furthermore, when a recombinant
baculovirus containing the mutated coding region of
La protein was expressed in SF9 cells the baculovirus
also allowed the expression of full length protein.
However, the full length La protein expression was
less efficient and the majority of La protein was
fragmented to the N- and C-terminal La protein
domain. The N-terminus remained in the cytoplasm,
the C-terminus entered in the nucleus and assembled
with nuclear speckles.
2. Materials and methods
2.1. Materials
A˝aII, BamHI, BstEII, KpnI, XhoI, and T7-Se-
quencing kit were obtained from Pharmacia Frei-
. burg, Germany ; NcoI from MBI Fermentas St.
.Leon-Rot, Germany ; pQE-60W, QIAprep-spin kit
 .and QIAEX from Qiagen Hilden, Germany ; T.C.
100 medium, Lipofectin and Taq polymerase from
Gibco BRL Life Technologies Eggenstein, Ger-
.  .many ; pET-3d AGS, Heidelberg, Germany ; pBlue-
 . script SK y from Stratagene GmbH Heidelberg,
.Germany ; CDP-Star TRopix, and pGEM-T vector
 .systems from Promega Serva, Heidelberg, Germany ;
Baculogold DNA, and pVL 1393 from Dianova
 .Hamburg, Germany ; BstXI, HindIII, Taq-buffer
 .10= , DNA molecular weight marker VI, positively
 .charged nylon membrane 1209272 , and blocking
reagent from Boehringer Mannheim Mannheim,
.Germany ; agarose and NuSieve agarose from Biozym
 .Hameln, Germany ; anti-mouse IgG conjugated with
 X. .peroxidase developed in sheep Fab fragments2
adsorbed with human serum proteins A-7282; 20
.  .Urml , anti-human IgG g-chain specific conjugated
 .with alkaline phosphatase A3150; 8 Urml , and
 .isopropyl b-D-thiogalactopyranoside IPTG from
 .Sigma St. Louis, MA, USA ; the ECL-Western blot-
ting detection reagents were from Amersham-Buchler
 .Braunschweig, Germany ; 4-Nitro-blue-tetrazolium
 .chloride NBT and 5-bromo-4-chloro-3-indolyl
 .  .phosphate BCIP from Roth Karlsruhe, Germany ;
 .PVDF-membrane IPVH 000 10; pore size 0.45 mm
 .was obtained from Millipore Bedford, MA, USA .
2.2. Monoclonal antibodies and sera
 .Two monoclonal anti-La antibodies anti-La mAb
and a patient anti-La antibody were used. The anti-La
mAb La4B6 was elicited by immunization of BalbrC
An mice with recombinant human La protein. The
epitope recognized by the anti-La mAb La4B6 was
shown to be the aa sequence 331SKGR-
RFKGKGKGN343. This region includes the putative
ATP-binding site of the La protein within the C-
w xterminal domain 9 . The anti-La mAb SW5 was
w xoriginally described by Smith et al. 15 . It was
shown to be directed to the N-terminal domain of La
w xprotein 16 and kindly provided by Prof. Dr. van
 .Venrooij University of Nijmegen, The Netherlands .
The patient anti-La antibody was obtained from the
 . w xserum of the patient Ma 13 . It was immunoad-
sorbed to recombinant La protein.
2.3. Cell culture and staining procedures
SF9 cells were grown in T.C. 100 medium con-
taining 10% FCS to a density of about 106 cellsrml.
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Then the cells were infected with 10 pfurcell of the
 .respective recombinant baculovirus see below . 40 to
50 h p.i. the cells were harvested for the preparation
 .of extracts see below . Prior to the preparation of
extracts 100 ml aliquots of infected or uninfected SF9
cells were taken and centrifuged to coverslips at
200=g for 2 min at room temperature using a
 .Cytofuge Heraeus, Hanau, Germany .
The cells were fixed with methanol containing
0.02% EGTA at y208C for 1 h. Prior to immuno-
staining the cells were rehydrated for 5 min with
PBS. Then the cells were incubated with cell culture
supernatant of hybridomas secreting the respective
anti-La mAb for at least 15 min. The cells were
 .washed with PBS 5 min and the bound anti-La
mAb was detected using Cy3-conjugated anti-mouse
antibody developed in goat. Indirect immunofluo-
rescence labeling using immunoadsorbed patient anti-
La antibody was performed using the same proce-
dure. The bound human anti-La antibody was de-
tected with species-specific anti-human antibody con-
 .jugated with Fluorescein FITC . For double
immunofluorescence, the cells were first stained with
the respective anti-La mAb and the anti-mouse anti-
body conjugated with the fluorescent dye Cy3 as
described above. Then the cells were additionally
incubated with the patient anti-La antibody. The de-
tection of the bound human autoantibody was per-
formed using anti-human antibody conjugated with
FITC. In all cases the incubation time for the sec-
ondary antibody was 15 min. The staining occurred at
room temperature. The unbound secondary antibodies
 .were removed by washing with PBS twice, 5 min .
The stained cells were mounted using PBSrglycerol
 w x.1:1 vrv .
2.4. Preparation of extracts
Total extracts were prepared from uninfected SF9
cells or SF9 cells which were infected with either
wildtype baculovirus or the respective recombinant
 .baculovirus see below . 40 ml cell suspension was
harvested by centrifugation 14 000=g for 5 min at
.48C , resuspended in 1.4 ml of cell lysis buffer,
heated for 5 min to 958C and centrifuged at 14 000=g
for 5 min at 48C. 5 ml aliquots were mixed with
w xSDS-PAGE sample solution 17 and used for SDS-
PAGE.
2.5. SDS-polyacrylamide gel electrophoresis and im-
munoblotting
SDS-PAGE was performed according to Laemmli
and immunoblotting to PVDF membrane according
w xto Matsudaira 17,18 . After blocking and washing
the blots were incubated with cell culture supernatant
 .Fig. 1. Comparison of the exon 7 sequence of the La cDNAs La19 and La23. A Identification of a frame shift mutation in the La cDNA
 .  .  .La23 lanes c,d but not in the La cDNA La19 lanes a,b . The interesting region was sequenced from both orientations revs reversed .
 .  .The bars indicate the localization of the correct oligo A fragment in the exon 7 in the La19 cDNA lanes a,b and the localization of the8
 .  .  .  .deleted oligo A fragment in La23 lanes c,d . B Comparison of the nt sequences of La19 EMBL Acc. Nr. X69804 , La23 and the La7
  ..  .pseudogenes PS1 to 3; EMBL Acc. Nrs. X91336; X91337; X91338 . The box shows the lack of a single A -residue in La23 compared
 .to La19. y indicates the lack of a nt in the respective sequence compared to the longest insert in the exon 7 of PS3. The arrows mark
the start and end of exon 7.
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of hybridoma cells secreting the anti-La mAb La4B6
or SW5. Formed immune complexes were visualized
 .using the enhanced chemiluminescence ECL -West-
ern blotting detection reagents. Then the immune
complexes were eluted and the blot was incubated
with the human anti-La serum. The formed immune
complexes were detected using anti-human antibodies
conjugated with alkaline phosphatase and BCIPrNBT
as substrate. In case that the blot was analyzed with
the anti-La mAb SW5 followed by the anti-La mAb
La4B6 the second detection was also performed with
the ECL system.
2.6. Confocal laser scanning microscopy
 .Confocal laser scanning microscopy cLSM was
performed using a Zeiss LSM 10. The stained speci-
mens were cut automatically into horizontal sections
512 = 512 pixelsr8 bit, objective lenses Plan-
.Neofluar 40=r1.3 oil . Evaluation of the stored
stacks of the horizontal optical sections was per-
formed with the LSM 10 image processing unit.
2.7. DNA sequence analysis
DNA was prepared using the QIAprep-spin kit and
concentrated by ethanol precipitation to a final con-
w xcentration of about 1 mgrml in TE buffer 19 . DNA
sequencing was performed as described previously
w x14 .
2.8. Construction of the recombinant baculo˝iruses
Recently two La cDNAs, which were obtained by
immunoscreening of a cDNA library of PBL of a
patient with pSS with the patient’s own autoimmune
serum, were characterized La19rLa23; EMBL Acc.
w x.Nr. X69804; 14 . The clone La23 contained a dele-
 .tion of an A -residue in the protease sensitive region
 .between the N- and C-terminal fragment Fig. 1 .
This La cDNA was used to construct a recombinant
baculovirus according to the following strategy: the
core portion of the La cDNA spanning from the
. XKpnI site to the A˝aII site was isolated. The 5 - and
3X-portions were modified by use of a PCR technique.
For the 3X-portion we used as the upstream primer P1
 .P1:CGAAATTTGCTAGTGATGATGAACA and
as downstream primer P2 P2:TGGTTTGGATCCC-
TACTGGTCTCCAG; the artificial BamHI site
 .neighbouring the stop codon TAG CTA is under-
.lined . The resulting fragment was cut by A˝aII and
 .BamHI and subcloned into pBluescript SK y . The
5X-end was created as follows.
In the regular La mRNA form translation starts at
the first AUG locating in the exon 2. Such a 5X-termi-
nal construct was prepared from the cDNA La23 by
PCR using the primer P3 P3:ACATAGGATCCAT-
GGCTGAAAATGGT; the artificial BamHI site
neighbouring the translational start ATG is under-
. lined as upstream primer and P4 P4:TGTTGTTAG-
.ACGGTTCAACCTGTTG as downstream primer.
The PCR fragment was cleaved by BamHI and KpnI
and cloned into the corresponding sites of pBluescript
 . SK y resulting in the construct pBSLa pBluescript
.containing the La coding region .
In order to express the La protein reading frame in
E. coli pBSLa was cut with NcoIrBamHI and cloned
into the respective cloning sites of pQE-60W. Thereby
a C-terminally His-tagged La protein construct was
obtained. As the expression of His-tagged La protein
from this construct was low, it was further subcloned
into the expression vector pET-3d using the
NcoIrHindIII sites. This construct expressed C-
 .terminally His-tagged La protein Fig. 3 .
The constructs for cloning into pVL 1393 were
rearranged using the different portions after cleavage
by KpnI, BamHI and A˝aII. The whole molecules
were cloned into the BamHI site of pVL1393.
The cotransfection for the production of the infec-
tious recombinant baculovirus was performed as fol-
lows. First a mixture consisting of 0.4 mg of the
construct, 0.1 mg Baculogold DNA, and 30 mg Lipo-
fectin within 50 ml of distilled water was prepared in
polysterene tubes. After 15 min at room temperature
1 ml T.C. 100 medium without FCS was added and
transferred to 6=105 SF9 cells seeded in a Petri dish
 .ds3 cm and incubated for 4 h at 278C. Then 1 ml
T.C. 100 medium containing 10% FCS was added.
After seven days the supernatant containing the re-
combinant viruses was harvested by centrifugation
 .14 000=g for 15 min at room temperature and
used for further amplification of the virus titer. Stock
solutions were prepared and stored at 48C for infec-
tion and expression of the respective La proteins.
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3. Results
3.1. Identification of a frame shift mutation in the
exon 7 of the La cDNA La23
When the La cDNA La19 was used for sequencing
 .  .an oligo A stretch of 8 A -residues was detectable
in the exon 7 starting at nt position 1054 Fig.
.  .1A,a,b . The same oligo A -stretch had also been
reported in a series of other human La cDNAs EMBL
Acc. Nrs. X13697; R20464; M20328; J04205;
.M11108; M35263 . In contrast, the La cDNA La23
 .  .showed a deletion of an A -residue in this oligo A -
 .stretch Fig. 1 A, c,d . The different lengths of the
 .oligo A -stretches in the two La cDNAs were con-
firmed when sequencing was performed from both
orientations. The deletion located in the protease
sensitive region, where La protein can be cleaved
resulting in the 29 kDa N-terminal and 25 kDa
w xC-terminal fragment 4 . Interestingly, the deletion
located at the same site, where the three La pseudo-
 .genes EMBL Acc. Nrs. X91336; X91337; X91338
 .contained more or less homogenous oligo A inserts
 .Fig. 1 B .
3.2. The frame shift mutation in the coding sequence
of the La cDNA La23 is efficiently corrected by a
ribosomal frame shift in E. coli
The deletion altered the reading frame in the La
mRNA derived from the La cDNA La23 and leads to
 .a premature stop codon 11 amino acids aa down-
stream of the frame shift site. Therefore one would
expect that translation should cause the addition of
 .the 11 aa MKKENKIKWKLN to the C-terminus of
the N-terminal domain of La protein. Downstream of
these aa translation should stop at the following first
 )..in frame stop codon Fig. 2 . The resulting
translational product should have a molecular weight
of about 29 kDa similar to the N-terminal proteolyti-
cal degradation product.
However, when the pET-3d construct, which con-
tained only the complete mutant La protein coding
 .region was expressed in E. coli Fig. 3 A , a protein
of about 50 kDa similar in size to full length La
 .protein was made Fig. 3 A, lanes a to h . As shown
 .in Fig. 3 A, lanes a,b a monospecific anti-La anti-
body adsorbed to recombinant La protein reacted
with this protein. The blot was eluted and cut into
two stripes. One stripe was analyzed using the anti-La
mAb SW5. The anti-La mAb SW5 is directed to an
epitope locating upstream of the frame shift mutation.
 .As shown in Fig. 3 A lane d the anti-La mAb SW5
also reacted with the 50 kDa protein. The second
stripe was analyzed with the anti-La mAb La4B6,
which recognizes an epitope, that locates downstream
of the frame shift mutation. As shown in Fig. 3 A
 .lane c the anti-La mAb La4B6 also reacted with the
50 kDa protein. In addition to the full length La
protein the patient anti-La antibody reacted with two
protein fragments of 29 and 25 kDa Fig. 3 A, lanes
.a,b . In agreement with earlier studies, the reactivity
 . Fig. 2. Consequences of the frame shift mutation in the La cDNA La23. Partial nt sequence of La19 H, 961–1200 and La23 P,
.  .  .961–1199 and the deduced partial aa sequence of La19 H, 160–239 and La23 P, 160–205, 223–239 .
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to the C-terminal fragment was less efficient and only
w xdetectable when overexposing the blot 9 . The 29
kDa band was also detected by the anti-La mAb SW5
 .Fig. 3 A, lane d . In contrast the anti-La mAb SW5
did not react with the 25 kDa band. Vice versa the
anti-La mAb La4B6 reacted with the C-terminal frag-
 .ment of about 25 kDa Fig. 3 A, lane c , but not with
the 29 kDa N-terminal fragment. When the total
 .extract containing i full length La protein being
 .reactive with the anti-La mAb SW5 Fig. 3 A, lane g
 .  .and the anti-La mAb La4B6 Fig. 3 A, lane e , ii
 .  .the N-terminal Fig. 3 A, lane g , and iii the
 .C-terminal fragment Fig. 3 A, lane e , were passed
through an Nickel affinity column the full length La
protein could be detected in the eluate of the column
 .with both, the anti-La mAb SW5 Fig. 3 A, lane h
 .and the anti-La mAb La4B6 Fig. 3 A, lane f .
Moreover, in addition to the full length La protein,
the C-terminal fragment was also eluted from the
column and detectable with the anti-La mAb La4B6
 .Fig. 3 A, lane f . In contrast, the not-tagged N-termi-
nal La protein fragment was removed during this
 .purification step Fig. 3 A, lane h .
From these results it is obvious that the His-tag
and the two C-terminal locating La epitopes recog-
nized by either the anti-La mAb La4B6 or the patient
anti-La antibody located in the reading frame of the
N-terminal La protein fragment. Thus the 50 kDa
protein expressed from the mutant La cDNA repre-
sented full length La protein. In consequence, the
region around the deletion must contain an efficient
ribosomal frame shift site.
3.3. The ribosomal frame shift e˝ent occurring in E.
coli also occurs in SF9 cells infected with a recombi-
nant baculo˝irus
In the next step the coding region containing the
deletion was used to construct a recombinant bac-
 .ulovirus. As shown in Fig. 3 B, lanes o,q extracts
obtained from SF9 cells infected with this bac-
ulovirus indeed contained full length La protein. The
full length La protein reacted with both, the anti-La
 .mAb SW5 Fig. 3 B, lane o and the anti-La mAb
 .La4B6 Fig. 3 B, lane q . However, the amount of
full length protein was less if compared to the bacte-
rial expression. The SF9 cell extracts contained pre-
dominantly the N- and C-terminal La protein frag-
ments. The N-terminal La protein fragment was reac-
tive with both, the anti-La mAb SW5 Fig. 3 B, lane
.  .o and the patient’s anti-La antibody data not shown .
The C-terminal fragment reacted with the anti-La
 .mAb La4B6 Fig. 3, lane q . Extracts obtained from
SF9 cells infected with wild-type baculoviruses did
not react with the anti-La mAbs Fig. 3B, lanes
.k,n,p,r . In order to rule out that the N- and C-termi-
Fig. 3. Protein products expressed from the frame shift mutated La mRNA in E. coli or the SF9rbaculovirus system. E. coli extracts A,
.  .  .lanes a to h . SF9rbaculovirus extracts B, lanes i to r . The extracts were either detected with the patient anti-La antibody lanes a,b , or
 .  .the anti-La mAb SW5 lanes d,g,h,l to p , or the anti-La mAb La4b6 lanes c,e,f,i to k,q,r . Lane M: 1 to 5 positions of marker proteins.
 .  .  .  . 1s97.5 kDa, 2s66 kDa, 3s45 kDa, 4s31 kDa, 5s21.5 kDa. A lanes c,d same blot as lanes a,b ; lanes e,f same blot as lanes
.  .  .  .g,h ; total E. coli extracts lanes a to e,g ; eluates from a nickel affinity column lanes f,h . B SF9 cell extract of cells infected with
 .recombinant baculoviruses expressing the correct La protein reading frame lanes i,l ; SF9 cell extract of cells infected with recombinant
 .baculoviruses expressing the mutant La protein reading frame lanes j,m,o,q ; SF9 cell extract of cells infected with wildtype
 .  .baculoviruses lanes k,n,p,r . In order to identify full length La protein in the extract analyzed in lanes j,m the gel had to be overloaded
 .in lanes o,q .
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nal fragments were the results of a proteolytical
degradation, SF9 cells were infected with a recombi-
nant baculovirus containing the correct La protein
 .reading frame Fig. 3 B, lanes i,l . In parallel SF9
cells were infected with the mutant recombinant bac-
 .ulovirus Fig. 3 B, lanes j,m . As shown in Fig. 3 B
 .lanes i,l the recombinant baculovirus containing the
correct La protein frame resulted predominantly in an
expression of full length La protein Fig. 3 B, lanes
.l,i . The full length La protein reacted with both, the
 .anti-La mAb SW5 Fig. 3 B, lane l and the anti-La
 .mAb La4B6 Fig. 3B, lane i . Only a minor amount
of an additional C-terminal La protein fragment was
detected with the anti-La mAb La4B6, while no
N-terminal proteolytical fragment was detectable un-
der the used conditions. No full length La protein was
detectable in the extract of the SF9 cells infected with
the recombinant mutant La protein Fig. 3B, lanes
.  .j,m . Only the N- Fig. 3 B, lane m and the C-termi-
 .nal Fig. 3B, lane j La protein fragments were
detected. Due to lack of a His-tag the C-terminal
fragment of the recombinant mutant baculovirus Fig.
.3B, lane j had a slightly higher mobility than the
C-terminal fragment of the recombinant baculovirus
which contained a C-terminal His-tag Fig. 3B, lane
.i .
From these results we concluded that the frame
shift can also occur in the baculorSF9 cell system,
but the majority of La protein existed as two frag-
ments, the N-terminal 29 kDa and the C-terminal 25
kDa fragment.
3.4. Localization of the N- and C-terminal La protein
fragment in SF9 cells
As the N-terminal fragment contains the RNP
consensus sequence and the C-terminal fragment con-
tains the putative nuclear localization signals and
ATP-binding site, we looked for the localization of
the two La protein fragments in SF9 cells infected
with the recombinant baculovirus. The cells were
 .either stained with the anti-La mAb La4B6 Fig. 4a ,
 .the anti-La mAb SW5 Fig. 4c,d or the patient’s
 .anti-La antibody Fig. 4b . As shown in Fig. 4 the
 .patient’s anti-La antibody Fig. 4b and the anti-La
 .mAb SW5 Fig. 4c,d stained predominantly the cy-
toplasm of SF9 cells. In contrast, the anti-La mAb
 .La4B6 stained predominantly the nucleus Fig. 4a
Fig. 4. Detection of La peptides in SF9 cells. SF9 cells infected
 .with wildtype baculoviruses f,g stained with a mixture of all
used primary and secondary antibodies, overlay of the FITC and
 .RITC image g . SF9 cells infected with the recombinant mutant
 .  .La baculovirus a to e . a,b double immunofluorescence of the
 .  .anti-La mAb La4B6 a with the patient’s anti-La antibody b .
 .a,b are overlays of ten optical sections obtained with cLSM.
 .  .c,d staining pattern of the anti-La mAb SW5. e,f correspond-
ing phase contrast images.
and gave a nuclear speckled type pattern. A similar
nuclear speckled type pattern is usually found for all
the anti-La antibodies including the SW5, the patient’s
w xanti-La antibody and the La4B6 on cultured cells 9 .
 .From these results we concluded, that i the N-
terminal fragment was not able to enter in the nucleus
 .of SF9 cells, ii the C-terminus contained the nuclear
 .location signal, iii the N-terminal RNP-consensus
motif was not essential for assembly of La protein
 .with nuclear speckles and, iv the cytoplasmic stain-
ing of the anti-La antibodies was not due to a leakage
of La protein at least under these conditions.
4. Discussion
Frequently sera of patients with pSS or SLE con-
tain self-reacting antibodies directed to nuclear anti-
gens. One of the targets of such ANAs is the nuclear
w xautoantigen LarSS-B 1 . It was proposed to be
involved in transcriptionrtermination of RNA poly-
w xmerase III 12,13 and in internal initiation of transla-
 . w xtion especially of polio virus mRNAs 11 .
In a recent study we searched for alternative La
mRNAs by screening of a cDNA library made from
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PBL of a patient with pSS with her own anti-La
serum. Thereby five La cDNAs were isolated. Among
them two La cDNAs La19, La23; EMBL Acc.Nr.
.X69804 were found, in which the exon 1 was re-
placed with the alternative exon 1X. Analysis of the La
gene showed that the transcription of the alternative
La mRNA started in the intron between the exons 1
and 2 using a promoter switch. The resulting tran-
script was processed using an alternative splicing
pathway.
The structure of the exon 1X La mRNA was un-
usual as it contains a GC-rich 5X-terminus, three
staggered ORFs upstream of the La protein reading
 .  .frame and an oligo U -tail of 23 U -residues. In
order to analyze the function a series of constructs
were made. During these cloning steps we noticed
that the La cDNA La23 contained a deletion of an
 .A -residue in the coding region. The frame shift
mutation located within the exon 7. During discus-
sion of our data we were told that a similar La cDNA
was isolated from a human liver cDNA library. This
 .La cDNA contained an insert of a single A -residue
at the same position Dr. Haubruck, Dr. Stahnke, Fa.
ELIAS, Freiburg, Germany, personal communica-
.tion . When the genomic DNA of the pSS patient was
 .analyzed no mutation was detected data not shown .
Thus, the frame shift mutation in the patient’s La
cDNA was either a mistake of reversed transcriptase
during preparation of the La cDNA library or the
result of a somatic mutation. As the cDNA library
was prepared from PBL the mutation had to be
expected in one of the B- or T-cells, or the
macrophages of the patient.
Most recently we characterized and sequenced the
three La pseudogenes EMBL Acc. Nrs. X91336;
.X91337; X91338; to be published . The pseudogenes
represented retrogenes as they lacked introns. More-
over, inverted repeats were found flanking the pseu-
dogene sequences. The retrogenes were termed PS1
to PS3. In PS1 and PS3 exon 1 La mRNAs were used
as templates of the La cDNAs. PS2 was the reversed
transcript of an alternative exon 1X La mRNA. Based
on the total amount of mutations in the respective
pseudogene we calculated the evolutionary age with
 .  .  .4 PS1 , 4.5 PS2 and 5 PS3 million years. The
calculation was performed according to Lin and Chan
w x20 .
During sequence analysis of the retrogenes we
noticed that the frame shift mutation in the La cD-
NAs located just at the same position where in all the
three La pseudogenes inserts of more or less long
 .oligo A -stretches of different lengthes ranging from
 .  .  .4 PS1 to 16 PS2 to 24 nts PS3 occurred in
 .addition to an oligo A -stretch. In consequence, the8
 .oldest pseudogene contained the longest oligo A -32
stretch, while the youngest pseudogene contained the
 .shortest oligo A -stretch in the exon 7.12
As in the case of the deletionrinsert in the La
 .cDNAs, the inserts of the A -residues in the
retropseudogenes could be explained by the same
mechanisms. They were the result of either mistakes
which occurred during reversed transcription or so-
matic mutations in a hot spot region in the exon 7 of
the La gene and pseudogenes. Mistakes made by
reversed transcriptase appeared to be rather unlikely
for several reasons. Until now more than 30 human
La cDNAs had been isolated from independent groups
w x4,22–26 . Only in the two La cDNAs frame shift
mutations were found in the exon 7. Therefore, it
appears rather unlikely that reverse transcriptase has
 .inserted up to 24 A -residues in just all those three
transcripts which were then inserted as retrogenes in
the human genome. Moreover, based on the age of
the individual retrogene it is obvious that the oldest
 . pseudogene PS3 contained the longest insert 24
.  .residues , while the youngest pseudogene PS1 con-
  . .tained the shortest insert 4 A -residues . As ho-
mopolymeric sequence increase the probability of
recombinations and thereby decrease the stability of a
genome, homopolymeric sequences especially the 3X-
 .poly A -tails of pseudogenes are usually rapidly
deleted or mutated. Therefore, one would expect, that
 .the length of the oligo A -stretches in the exon 7 will
be mutated and lost during further evolution, but
should not increase. This assumption is in good
agreement with the following observation. As men-
tioned above PS2 is a derivative of an alternative
exon 1X La mRNA. Thus the exon 1X La mRNA
which was used as template for the retrogene con-
 .tained a further homopolymeric oligo U -stretch of
 . X23 uridine residues. When looking to the exon 1
 .sequence of PS2, it is obvious that this oligo dT -
stretch was partially deleted and mutated. Thus the
evolutionary time was enough to mutate this
 . X Xoligo dTrd A -stretch in the 5 -exon 1 . In contrast,23
 .the oligo d ArdT -stretch in the exon 7 was con-24
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served in the same pseudogene without any selection
pressure. Therefore, from our point of view, it ap-
 .pears more likely that the already existing oligo A -
 . stretch of 8 A -residues in the human La gene and 9
w x.in mouse and rat 21 and the further increase of
 .length of this oligo A -stretch in dependence on the
age of the pseudogenes is caused by an repeated
 .insert of A -residues but not the result of reversed
transcriptase mistakes. As an insert in the La gene
interfered with its function the frequency of an effi-
cient insert in the La gene was less than in the
pseudogenes. Taken together, the exon 7 might repre-
sent a hot spot region in the La gene and pseudo-
 .genes, where repeated inserts of A -residues can
occur. This is also of interest, as one of the major
autoepitopes of the La antigen was located in the hot
w xspot region 22 .
In consequence, the frame shift mutations in the
two La cDNAs located in a hot spot region of the La
genes. Therefore, it is also likely that the correspond-
ing template La mRNAs already contained these
mistakes. Thus they were transcripts from La genes
in a cell containing the respective somatic mutation.
Based on the deletion in the reading frame, we
expected that an expression of this La cDNA should
provide us with the N-terminal 29 kDa fragment of
La protein containing the RNP consensus sequence.
For this purpose the La coding region containing the
frame shift mutation was cloned in the pQE-60W
vector. During this cloning step a C-terminal
 .oligo His -tag was introduced in the reading frame of
La protein, which should allow us to remove C-termi-
nal La protein fragments when formed by internal
initiation. Unfortunately, this construct preferentially
expressed the C-terminal fragment indicating that an
internal translation initiation occurred downstream of
 .the frameshift site data not shown . The only AUG
 .which located i in the reading frame of La protein
 .and ii downstream of the frame shift site located at
  . .aa position M 223 ; Fig. 2 . Indeed, already during
epitope mapping of the anti-La mAb La4B6 this
 .M 223 was suggested to be involved in internal
initiation of translation. This conclusion based on the
following observation. The epitope recognized by the
 .anti-La mAb La4B6 SKGRRFKGKGKGN locates
 .downstream of M 223 . As the reactivity of the anti-
La mAb to E. coli extracts, which contained La
peptides expressed from 5X-terminally truncated La
deletion mutants, did not depend on the reading
 .frame of the b-Gal derived AUG until M 223 was
 .deleted it was concluded that M 223 allows an inter-
nal initiation and thereby an expression of a C-termi-
nally fragment of La protein independent of the
w xupstream located reading frame 9 . In consequence,
this C-terminal fragment starts at the same position
where the suggested 25 kDa C-terminal proteolytical
La protein fragment was found to start by protein
w xsequencing 4 .
In order to increase the efficiency of expression of
the N-terminus in a further attempt the La protein
reading frame containing the frame shift mutation
was cloned into pET-3d. Now, in addition to both,
the N- and C-terminal La protein fragments we ob-
tained a protein with a molecular weight according to
full length La protein. Moreover, the protein could be
purified by an Nickel affinity column chromato-
graphic step, which indicates that the C-terminal
 .oligo His -tag is in the correct La protein reading
frame. In addition, the full length protein reacted with
both anti-La mAbs directed to the N- or the C-
terminus as well as with the patient’s anti-La anti-
body directed to the N- and C-terminus. This indi-
cates, that at least two correct La epitope sequences
must exist in the C-terminus of the expressed protein.
Finally, there are a series of stop codons in the
reading frame downstream of the frame shift muta-
tion, which rule out that a 50 kDa protein can be
made from this reading frame for example by over-
reading the first in frame stop codon.
In summary, these data allowed the conclusion that
a ribosomal frame shift allowed an expression of the
full length La protein from the La cDNA containing
 .the frame shift mutation. Indeed, the long A -stretch
 .  .of 7 8 A -residues representing the hot spot region
also represents a putative ribosomal frameshift site
w x26 .
Our data show that translation when it starts at the
 .AUG encoding for M 1 and ending 11 aa down-
stream of the frame shift mutation site at the first in
frame stop codon results in a similar protein product
of 29 kDa as it is formed when a proteolytic cleavage
of full length La protein occurs in the proteolytic
sensitive region. Furthermore, a reinitiation or an
 .internal initiation at M 223 also resulted in the same
C-terminal protein product of about 25 kDa as it is
formed when full length La protein is cleaved within
( )M. Bachmann et al.rBiochimica et Biophysica Acta 1356 1997 53–6362
the protease sensitive region. Therefore, at present we
cannot completely rule out that the N- and C-terminal
fragments present in the E. coli extracts and the
baculovirus infected SF9 cell extracts are the result of
a proteolytic degradation of the full length La protein.
However, a proteolytical degradation appears rather
unlikely, because an infection of SF9 with a recombi-
nant baculovirus expressing the correct La protein
reading frame resulted in an expression of full length
La protein with merely traces of degradation prod-
ucts. In contrast, when the recombinant baculovirus
containing the frame shift mutation was expresed in
parallel under identical conditions, it produced nearly
quantitatively N- and C-terminal La protein frag-
ments. It is important to mention that the expression
level was similar for both recombinant baculoviruses.
Therefore, the appearance of the La fragments cannot
be the result of a less efficient expression increasing
the possibility of a degradation of the full length La
protein. Having in mind that the full length La pro-
tein made from the mutant baculovirus by the use of
ribosomal frame shifting should have the same pri-
mary protein sequence as the native La protein, the
two La protein extracts should not differ with respect
to their amount of proteolytic degradation. Thus the
N- and the C-terminal La protein fragment made
from the mutant recombinant baculovirus might be
native translational products. In this case the transla-
tion of the C-terminal fragment required an efficient
 .internal initiation or reinitiation at M 223 as it was
found to occur in E. coli.
The presence of an internal reinitation site down-
stream of the hot spot region is also of interest from a
further evolutionary point of view. Most recently, La
w xrelated cDNAs were isolated from yeast 27,28 . Se-
quence comparisons show that only the N-terminal
fragment was conserved during evolution. One possi-
ble explanation could be that the mammalian La gene
is a fusion product of two genes in the hot spot
region. The functions of the mammalian La protein
could still be separated to two independent proteins
in the yeast system. Two distinct functions had been
attributed to La protein including a cytoplasmic func-
tion in internal initiation of translation and a nuclear
function in transcription.
Based on the cytoplasmic localization of the N-
terminal fragment and the nuclear staining of the
C-terminus, one could speculate that the nuclear func-
tion is related to the C-terminus and the N-terminus
could be related to the cytoplasmic function.
Both, the anti-La mAb SW5 and the patient’s
anti-La antibody stained predominantly the cytoplas-
mic compartment. As mentioned above the patient’s
anti-La antibody preferentially reacted with the N-
terminal La protein fragment. This explains why the
staining pattern of the patient’s anti-La antibody was
similar to the pattern of the anti-N-terminal reactive
anti-La mAb SW5. As summarized in the introduc-
tion section, the N-terminal fragment contains the
RNP-consensus motif, which was found to be re-
w xquired and sufficient for binding of La RNAs 5,6 . In
consequence, the possibility to bind to RNA via this
RNP-motif is not required for nuclear import and
assembly with the nuclear speckles.
Finally, the identification of a ribosomal frame
shift site in the hot spot region could also be involved
in the formation of neoepitopes in virus infeced cells
and thereby important for triggering of the autoim-
mune response.
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